Research and Markets: Global Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Market 2012-2016

Posted: Published on June 11th, 2013

This post was added by Dr P. Richardson

DUBLIN--(BUSINESS WIRE)--

Research and Markets (http://www.researchandmarkets.com/research/fllmw4/global) has announced the addition of the "Global Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Market 2012-2016" report to their offering.

TechNavio's analysts forecast the Global Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs market to grow at a CAGR of 3 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increase in prevalence of the MRSA infection. The Global Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs market has also been witnessing the increase in Governmental/Non-Governmental awareness programs. However, the increasing generic competition could pose a challenge to the growth of this market.

The key vendors dominating this market space are Pfizer Inc., Cubist Pharmaceuticals Inc., ViroPharma Inc., Theravance Inc. and Forest Laboratories Inc.

The other vendors mentioned in the report are Basilea Pharmaceutica Ltd., Durata Therapeutics, Inc., Novartis AG, Trius Therapeutics, Inc., AstraZeneca plc., and GlaxoSmithKline plc.

TechNavio recognizes the following companies as the key players in the Global Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Market: Pfizer Inc., Cubist Pharmaceuticals Inc., ViroPharma Inc., Forest Laboratories Inc., and Theravance Inc.

Commenting on the report, an analyst from TechNavio's Healthcare team said: 'The most common trend witnessed in the Global MRSA Drugs market is various governmental and non-governmental awareness programs that are informing people about the advanced treatments and educating people about the spread of infections. Moreover, vendors are supporting such comprehensive care programs through awareness campaigns for educating people about the spread and the treatment of infectious diseases.'

According to the report, the increase in the prevalence of MRSA infections has increased the usage of drugs used against MRSA infection across the globe.

For more information visit http://www.researchandmarkets.com/research/fllmw4/global

About Research and Markets

The rest is here:
Research and Markets: Global Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Market 2012-2016

Related Posts
This entry was posted in Drugs. Bookmark the permalink.

Comments are closed.